Shots:
- Thermo Fisher Scientific has received FDA 510(k) clearance for the EXENT Analyser & Immunoglobulin Isotypes (GAM) Assay, an automated mass spectrometry-based platform, for aiding diagnosis of MM & related conditions
- The EXENT System detects & isotypes low-concentration M-proteins with high sensitivity to identify them by molecular weight, differentiating endogenous from therapeutic antibodies & providing clear, automated results to enhance diagnostic accuracy & confidence
- EXENT enables high sensitivity, automation, & workflow efficiency with 6hrs. of walkaway time per shift, & is available across the US, Canada, EU, Australia, the UK, Brazil, & New Zealand
Ref: Businesswire | Image: Thermo Fisher | Press Release
Related News:- Thermo Fisher Scientific to Acquire Clario for ~$9.4B
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
